has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently licensed medication for the prevention of breast cancer. Research ...
Women treated with Arimidex for five years were 50% less likely to have developed breast cancer recurrence compared with women given placebo at nearly 11 years follow-up after stopping treatment.
Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: ...
The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that a ...
A study by researchers from Queen Mary University of London shows that bone loss known to be associated with the use of the breast cancer prevention drug Anastrozole partially reverses, particularly ...
Anastrozole, an aromatase inhibitor, is widely prescribed for oestrogen receptor-positive breast cancer. Although effective, it has been linked to autoimmune hepatitis (AIH), a rare but serious ...
Some bodybuilders take Arimidex to reduce the side effects of anabolic steroids. The drug is a breast cancer treatment that lowers estrogen levels, so a person should avoid using it for other means.
In addition, by the end of July, patients will be able to download the ARIMIDEX Savings Card on www.inyourcorner.com. Patients should present their ARIMIDEX Savings Card to a participating pharmacist, ...
Arimidex (anastrozole) is a brand-name oral tablet prescribed for certain forms of breast cancer. Arimidex has interactions with some other drugs and certain supplements. Examples include estrogens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results